These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 24951441)

  • 1. Interplay between Candida albicans and the antimicrobial peptide armory.
    Swidergall M; Ernst JF
    Eukaryot Cell; 2014 Aug; 13(8):950-7. PubMed ID: 24951441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Looking into Candida albicans infection, host response, and antifungal strategies.
    Wang Y
    Virulence; 2015; 6(4):307-8. PubMed ID: 25590793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between Candida albicans and the mammalian innate host defense.
    Cheng SC; Joosten LA; Kullberg BJ; Netea MG
    Infect Immun; 2012 Apr; 80(4):1304-13. PubMed ID: 22252867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing Metal Homeostasis Offers Novel and Promising Targets Against Candida albicans.
    Hameed S; Hans S; Singh S; Fatima Z
    Curr Drug Discov Technol; 2020; 17(4):415-429. PubMed ID: 30827249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.
    Höfs S; Mogavero S; Hube B
    J Microbiol; 2016 Mar; 54(3):149-69. PubMed ID: 26920876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytes from Mice Lacking the Sts Phosphatases Have an Enhanced Antifungal Response to Candida albicans.
    Frank D; Naseem S; Russo GL; Li C; Parashar K; Konopka JB; Carpino N
    mBio; 2018 Jul; 9(4):. PubMed ID: 30018105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Candida albicans biofilm.
    Tsui C; Kong EF; Jabra-Rizk MA
    Pathog Dis; 2016 Jun; 74(4):ftw018. PubMed ID: 26960943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interactions between the Antimicrobial Peptide P-113 and Living
    Cheng KT; Wu CL; Yip BS; Chih YH; Peng KL; Hsu SY; Yu HY; Cheng JW
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSD1 is integral to host defense peptide resistance in Candida albicans.
    Gank KD; Yeaman MR; Kojima S; Yount NY; Park H; Edwards JE; Filler SG; Fu Y
    Eukaryot Cell; 2008 Aug; 7(8):1318-27. PubMed ID: 18515753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune cell response upon Candida albicans infection.
    Qin Y; Zhang L; Xu Z; Zhang J; Jiang YY; Cao Y; Yan T
    Virulence; 2016 Jul; 7(5):512-26. PubMed ID: 27078171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histatin 5 Metallopeptides and Their Potential against
    Zolin GVS; Fonseca FHD; Zambom CR; Garrido SS
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm of Candida albicans: formation, regulation and resistance.
    Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
    J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial peptide LL-37 disrupts plasma membrane and calcium homeostasis in
    Chen S-Y; Chang C-K; Lan C-Y
    Microbiol Spectr; 2023 Dec; 11(6):e0255123. PubMed ID: 37888991
    [No Abstract]   [Full Text] [Related]  

  • 14. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
    Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
    J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMT-based quantitative proteomic analysis of the effects of novel antimicrobial peptide AMP-17 against Candida albicans.
    Yang LB; Guo G; Tian ZQ; Zhou LX; Zhu LJ; Peng J; Sun CQ; Huang MJ
    J Proteomics; 2022 Jan; 250():104385. PubMed ID: 34606990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexity and dynamics of host-fungal interactions.
    Cottier F; Pavelka N
    Immunol Res; 2012 Sep; 53(1-3):127-35. PubMed ID: 22415250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans.
    Luo S; Skerka C; Kurzai O; Zipfel PF
    Mol Immunol; 2013 Dec; 56(3):161-9. PubMed ID: 23809232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida albicans drug resistance another way to cope with stress.
    Cannon RD; Lamping E; Holmes AR; Niimi K; Tanabe K; Niimi M; Monk BC
    Microbiology (Reading); 2007 Oct; 153(Pt 10):3211-3217. PubMed ID: 17906120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.
    Raman N; Lee MR; Rodríguez López AL; Palecek SP; Lynn DM
    Acta Biomater; 2016 Oct; 43():240-250. PubMed ID: 27422198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.
    Basso V; Garcia A; Tran DQ; Schaal JB; Tran P; Ngole D; Aqeel Y; Tongaonkar P; Ouellette AJ; Selsted ME
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.